As of January 22, 2025, Vigil Neuroscience (VIGL) has a market cap of $82.985 million USD. According to our data, Vigil Neuroscience is ranked No.7831 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $82.99 M |
19.41%
|
Dec 31, 2024 | $69.50 M |
-49.70%
|
Dec 29, 2023 | $0.14 B |
-72.96%
|
Dec 30, 2022 | $0.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Denali Therapeutics
DNLI
|
$3.35 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Market Cap | = | VIGL Stock Price | * | VIGL Shares Outstanding |
= | $2.03 | * | 40.88 M | |
= | $82.99 M |